Platform Medicine and Patient Autonomy: A Socio-Epistemological Analysis of Taxonomic Shifts and Informed Consent in mRNA Deployments

The rapid deployment of synthetic messenger RNA (mRNA) technologies is conventionally framed within the historical lineage of traditional vaccinology. This conceptual essay examines an important and underexplored bioethical question: whether classifying an intracellular transfection platform as a conventional vaccine alters the epistemic conditions of disclosure, thereby straining the prerequisites for genuine informed consent. Applying a time-indexed, socio-epistemological framework, this analysis evaluates the institutional communication operating at initial rollout up to a 2026 data cut-off. The investigation is grounded in the bioethical autonomy frameworks of Beauchamp and Childress, the communicative ethics of Onora O’Neill, the social epistemology of Miranda Fricker, and contemporary advancements in RNA synthetic biology. We demonstrate that substituting an in vivo digital-to-analog code platform with a domesticated vaccine analogy created a significant taxonomic mismatch. While public messaging emphasized a localized, predictable biological input, the platform paradigm introduces systemic biodistribution and highly variable, host-dependent translation kinetics. While these newer scientific insights do not establish subjective institutional intent at rollout, they retrospectively validate the ex ante boundaries of technological predictability. Consequently, the systematic redistribution of epistemic uncertainty from upstream institutional architects to downstream actors compromised the cognitive baseline required for fully autonomous decision-making. To preserve biomedical integrity in an era of proliferating platform architectures, bioethics must transition from substance-based risk disclosure toward platform-specific consent architectures. We propose concrete parameters for advanced consent protocols that transparently disclose the evolving epistemic status, predictive limits, and legal liability distributions of modular biotechnologies.

Authors

Publication Details

Journal
Journal of Independent Medicine
Published
2026-11-18
DOI
https://doi.org/10.71189/jim/2026/v02n06a08
Primary Topic
Ethics and bioethics in healthcare
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Platform Medicine and Patient Autonomy: A Socio-Epistemological Analysis of Taxonomic Shifts and Informed Consent in mRNA Deployments

Dietmar Kabelka
3 links
Journal of Independent Medicine
Ethics and bioethics in healthcare
article

Platform Medicine and Patient Autonomy: A Socio-Epistemological Analysis of Taxonomic Shifts and Informed Consent in mRNA Deployments

Dietmar Kabelka
article en

Abstract

The rapid deployment of synthetic messenger RNA (mRNA) technologies is conventionally framed within the historical lineage of traditional vaccinology. This conceptual essay examines an important and underexplored bioethical question: whether classifying an intracellular transfection platform as a conventional vaccine alters the epistemic conditions of disclosure, thereby straining the prerequisites for genuine informed consent. Applying a time-indexed, socio-epistemological framework, this analysis evaluates the institutional communication operating at initial rollout up to a 2026 data cut-off. The investigation is grounded in the bioethical autonomy frameworks of Beauchamp and Childress, the communicative ethics of Onora O’Neill, the social epistemology of Miranda Fricker, and contemporary advancements in RNA synthetic biology. We demonstrate that substituting an in vivo digital-to-analog code platform with a domesticated vaccine analogy created a significant taxonomic mismatch. While public messaging emphasized a localized, predictable biological input, the platform paradigm introduces systemic biodistribution and highly variable, host-dependent translation kinetics. While these newer scientific insights do not establish subjective institutional intent at rollout, they retrospectively validate the ex ante boundaries of technological predictability. Consequently, the systematic redistribution of epistemic uncertainty from upstream institutional architects to downstream actors compromised the cognitive baseline required for fully autonomous decision-making. To preserve biomedical integrity in an era of proliferating platform architectures, bioethics must transition from substance-based risk disclosure toward platform-specific consent architectures. We propose concrete parameters for advanced consent protocols that transparently disclose the evolving epistemic status, predictive limits, and legal liability distributions of modular biotechnologies.

Journal of Independent MedicineVol. 2(6)
Good health and well-being
Ethics and bioethics in healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon